fda compounding semaglutide enforcement october 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA is moving to restrict
Description
10.1038/nm.3009 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Richard JE, Anderberg RH, Lpez-Ferreras L, Olandersson K, Skibicka KP
Semaglutide: Approved since 2017 with 7+ years post-marketing data
A third showed gradual improvement over 16 weeks with conservative management
WHEN YOU LOSE WEIGHT, YOURE LOSING FAT, BUT YOURE ALSO LOSING LEAN MUSCLE MASS AND BONE DENSITY
Sattar N, McGuire DK, Pavo I, et al
